POMC and ischemic stroke: In view of the controversial findings about DHEA, DHEAS and the low-dose (1 μg) ACTH-test as outcome predictors in ischemic stroke, we herein evaluated the predictive value of adrenal function testing in a cohort of prospectively recruited stroke patients [8] by measuring DHEA, DHEAS, basal and stimulated cortisol levels.